Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

364 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immune checkpoint blockade: a common denominator approach to cancer therapy.
Topalian SL, Drake CG, Pardoll DM. Topalian SL, et al. Cancer Cell. 2015 Apr 13;27(4):450-61. doi: 10.1016/j.ccell.2015.03.001. Epub 2015 Apr 6. Cancer Cell. 2015. PMID: 25858804 Free PMC article. Review.
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.
Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG. Marciscano AE, et al. Clin Cancer Res. 2018 Oct 15;24(20):5058-5071. doi: 10.1158/1078-0432.CCR-17-3427. Epub 2018 Jun 13. Clin Cancer Res. 2018. PMID: 29898992 Free PMC article.
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.
Paller CJ, Zhou XC, Heath EI, Taplin ME, Mayer T, Stein MN, Bubley GJ, Pili R, Hudson T, Kakarla R, Abbas MM, Anders NM, Dowling D, King S, Bruns AB, Wagner WD, Drake CG, Antonarakis ES, Eisenberger MA, Denmeade SR, Rudek MA, Rosner GL, Carducci MA. Paller CJ, et al. Clin Cancer Res. 2018 Jan 15;24(2):306-315. doi: 10.1158/1078-0432.CCR-17-1100. Epub 2017 Nov 7. Clin Cancer Res. 2018. PMID: 29113986 Free PMC article. Clinical Trial.
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.
Murtola TJ, Gurel B, Umbehr M, Lucia MS, Thompson IM Jr, Goodman PJ, Kristal AR, Parnes HL, Lippman SM, Sutcliffe S, Peskoe SB, Barber JR, Drake CG, Nelson WG, De Marzo AM, Platz EA. Murtola TJ, et al. Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):463-9. doi: 10.1158/1055-9965.EPI-15-0987. Epub 2015 Dec 29. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26715424 Free PMC article. Clinical Trial.
Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study.
Platz EA, Drake CG, Wilson KM, Sutcliffe S, Kenfield SA, Mucci LA, Stampfer MJ, Willett WC, Camargo CA Jr, Giovannucci E. Platz EA, et al. Int J Cancer. 2015 Aug 15;137(4):949-58. doi: 10.1002/ijc.29463. Epub 2015 Feb 27. Int J Cancer. 2015. PMID: 25648070 Free PMC article.
A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.
Bhavsar NA, Bream JH, Meeker AK, Drake CG, Peskoe SB, Dabitao D, De Marzo AM, Isaacs WB, Platz EA. Bhavsar NA, et al. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2561-7. doi: 10.1158/1055-9965.EPI-14-0010. Epub 2014 Aug 22. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25150281 Free PMC article.
Cancer immunotherapy highlights from the 2014 ASCO Meeting.
Harshman LC, Drake CG, Wargo JA, Sharma P, Bhardwaj N. Harshman LC, et al. Cancer Immunol Res. 2014 Aug;2(8):714-9. doi: 10.1158/2326-6066.CIR-14-0119. Cancer Immunol Res. 2014. PMID: 25092813
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.
Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, Bruno TC, Richmon JD, Wang H, Bishop JA, Chen L, Drake CG, Topalian SL, Pardoll DM, Pai SI. Lyford-Pike S, et al. Cancer Res. 2013 Mar 15;73(6):1733-41. doi: 10.1158/0008-5472.CAN-12-2384. Epub 2013 Jan 3. Cancer Res. 2013. PMID: 23288508 Free PMC article.
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody.
Lipson EJ, Sharfman WH, Drake CG, Wollner I, Taube JM, Anders RA, Xu H, Yao S, Pons A, Chen L, Pardoll DM, Brahmer JR, Topalian SL. Lipson EJ, et al. Clin Cancer Res. 2013 Jan 15;19(2):462-8. doi: 10.1158/1078-0432.CCR-12-2625. Epub 2012 Nov 20. Clin Cancer Res. 2013. PMID: 23169436 Free PMC article. Clinical Trial.
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.
Lipson EJ, Drake CG. Lipson EJ, et al. Clin Cancer Res. 2011 Nov 15;17(22):6958-62. doi: 10.1158/1078-0432.CCR-11-1595. Epub 2011 Sep 7. Clin Cancer Res. 2011. PMID: 21900389 Free PMC article. Review.
364 results
Jump to page
Feedback